Redeye updates on Zordix/Maximum Entertainment following its Q1-results which came in weaker than ex...
Med GRAS SA-godkänannde av CarbiAXOS runt hörnet står Carbiotix AB (”Carbiotix” eller Bolaget”) nu r...
Mangold updates Cyber Security 1 ("CYBER1") after the first quarter of 2023.
The main event since our last update is the conclusion of the rights issue in April.
Active Biotech has published new data in an ASCO 2023 abstract from the phase I/IIa study of tasquin...
Blick Global Group meddelade den 26 maj att dotterbolaget OMI Gaming nu har levererat och certifiera...
Redeye comments on Scandion Oncology’s Q1 2023 report, which follows a first quarter where the compa...
Redeye comments on the new readout in non-small cell lung cancer presented at ASCO 2023.
Redeye comments on today’s news from Sozap, where the company announced a rights issue which, if ful...
Redeye leaves its comments on Scandinavian ChemoTech following the company’s Q1 2023 report.
Redeye comments on TECO2030’s Q1-report, where we see that the company is progressing well operation...
(Rättelse avser bifogad länk) Gold Town Games publicerade den 25 maj år 2023 bolagets delårsrapport ...
PTS has published new statistics for the SE fibre market BRE2 market share: slightly down in subscri...
Redeye is encouraged by today's news, where Fantasma Games is finding new ways to monetize its slot ...
STRAX shows promising Q1 progress, banking on its core brands and cost optimization.
Redeye provides a first comment following Ngenic's release of its Q1 report.
Chordate har publicerat bolagets delårsrapport för första kvartalet 2023 och har dessförinnan kommun...
Northern CapSek Ventures (”CapSek”) rapport för det första kvartalet visade en stabil tillväxt för d...
Redeye provides an update on ChromoGenics following the company's Q1 2023 results.
Serneke delivered a mixed set of numbers for Q1, with the group EBIT margin slightly below our expec...
